Case study/ Focus: Infection Control

Microbicidal paint used in George healthcare facility oncology unit

The microbicidal properties were attractive given the compromised immune system of the patient population


Microbicidal paint was used in the oncology unit of Northside Hospital Healthcare System facility in Cummings, ga., according to a case study on from Sherwin-Williams Paint Shield. 

The microbicidal properties of the paint were attractive given the compromised immune system of the patient population.

Paint Shield is the first EPA-registered microbicidal paint and kills greater than 99.9 percent of Staph (Staphylococcus aureus), MRSA (Methicillin-resistant Staphylococcus aureus), E. coli (Escherichia coli), VRE (Vancomycinresistant Enterococcus faecalis) and Enterobacter aerogenes within two hours of exposure on the painted surface, according to the case study.

Download the Study



September 13, 2017


Topic Area: Infection Control


Recent Posts

Wesley Rehabilitation Center Specializes in Patients from Design to Care

Barge knew that patients were at the core of the design process.


Casa Colina Center for Disorders of Consciousness Officially Opens

New program addresses critical need for patients with severe brain injuries.


Legionella Detected at Michigan Health Facility

Case follows a similar finding of Legionnaires’ disease in a former patient.


Crystal Spring Tower Opens at Carilion Roanoke Memorial Hospital

The new cardiovascular institute improves access and care across the region.


Hospital Evacuation Highlights Importance of Emergency Preparedness

Berger Hospital was evacuated after smoke was discovered in the basement.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.